The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function
Abstract
BACKGROUND.: Various chemotherapy agents, especially of the alkylating category, have been associated with premature ovarian failure but there is no quantitative evidence of chemotherapy‐induced ovarian damage in humans. The aim was to quantify the impact of chemotherapy on primordial follicle reserve and stromal function in human ovary with a prospective controlled quantitative histologic and in vitro study. METHODS.: Samples from 26 patients who were undergoing ovarian tissue cryopreservation for fertility preservation were assessed histologically and for in vitro estradiol production. Of the 26 patients, 10 had previously received chemotherapy whereas 16 had not (control). There were 17 age‐matched patients. Primordial follicle counts and in vitro estrogen production were compared between age‐matched control and chemotherapy patients as well as between those who did and did not receive alkylating agents. RESULTS.: Patients who received chemotherapy had significantly lower primordial follicle counts than control patients (5.4 ± 1.32 vs 9.6 ± 2.2, P = .05). Furthermore patients treated with alkylating regimens had significantly lower primordial follicle counts compared with those who received nonalkylating agents (2.9 ± 1.1 vs 7.9 ± 1.6, P < .05) and with those who did not receive any chemotherapy (2.9 ± 1.1 vs 9.6 ± 2.2, P < .05). In vitro, ovarian cortical pieces from individuals who were previously exposed to chemotherapy (chemotherapy group) produced significantly less estradiol compared with those who were not (control group). In the chemotherapy group, there was no difference in in vitro estradiol production between those who received alkylating agents and those who did not. CONCLUSIONS.: This is the first quantitative evidence of the impact of chemotherapy on ovarian infrastructure, and shows that, whereas alkylating agents can significantly reduce ovarian reserve, both alkylating and nonalkylating regimens may affect ovarian stromal function. Cancer 2007. © 2007 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Germline stem cells and follicular renewal in the postnatal mammalian ovary
Johnson, J., Canning, J., Kaneko, T., Pru, J. K., & Tilly, J. L. (2004) · Nature · doi:10.1038/nature02316 · Cited by 1,278
Johnson, J., Bagley, J., Skaznik-Wikiel, M., Lee, H.-J., Adams, G. B., Niikura, Y., Tschudy, K. S., Tilly, J. C., Cortes, M. L., Forkert, R., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.031 · Cited by 700
Morita, Y., Perez, G. I., Paris, F., Miranda, S. R., Ehleiter, D., Haimovitz-Friedman, A., Fuks, Z., Xie, Z., Reed, J. C., Schuchman, E. H., et al. (2000) · Nature Medicine · doi:10.1038/80442 · Cited by 588
Fertility preservation in female patients
Sonmezer, M. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh021 · Cited by 496
Faddy, M. J., & Gosden, R. G. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019422 · Cited by 422
Oktay, K., Newton, H., Mullan, J., & Gosden, R. G. (1998) · Human Reproduction · doi:10.1093/humrep/13.5.1133 · Cited by 361
Self-citationOktay, K., Briggs, D., & Gosden, R. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4346 · Cited by 329
Self-citationEffects of Aging and Niche Microenvironment on Spermatogonial Stem Cell Self-Renewal
Ryu, B.-Y., Orwig, K. E., Oatley, J. M., Avarbock, M. R., & Brinster, R. L. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0580 · Cited by 265
Oktay, K. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.11.3748 · Cited by 263
Self-citationLee, H.-J., Selesniemi, K., Niikura, Y., Niikura, T., Klein, R., Dombkowski, D. M., & Tilly, J. L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.3028 · Cited by 263
Scheffer, G. J. (2003) · Human Reproduction · doi:10.1093/humrep/deg135 · Cited by 215
Oktem, O., & Oktay, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2042 · Cited by 212
Self-citationLutchman Singh, K., Davies, M., & Chatterjee, R. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmh052 · Cited by 169
Oktay, K. (2006) · Human Reproduction · doi:10.1093/humrep/del007 · Cited by 139
Self-citationMeasuring the Impact of Chemotherapy on Fertility in Women With Breast Cancer
Oktay, K., Öktem, Ö., Reh, A., & Vahdat, L. T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.9823 · Cited by 104
Self-citationOktay, K., Karlikaya, G., Akman, O. H., Ojakian, G. K., & Oktay, M. H. (2000) · Biology of Reproduction · doi:10.1095/biolreprod63.2.457 · Cited by 77
Self-citationGonadal Damage in Hodgkin’s Disease from Cancer Chemotherapeutic Regimens
Bonadonna, G., Santoro, A., Viviani, S., Lombardi, C., & Ragni, G. (1984) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-69132-4_16 · Cited by 51
Cited by
Ferraretti, A. P., La Marca, A., Fauser, B. C. J. M., Tarlatzis, B., Nargund, G., Gianaroli, L., & on behalf of the ESHRE working group on Poor Ovarian Response Definition (2011) · Human Reproduction · doi:10.1093/humrep/der092 · Cited by 1,882
Ovarian damage from chemotherapy and current approaches to its protection
Spears, N., Lopes, F., Stefansdottir, A., Rossi, V, De Felici, M., Anderson, R. A., & Klinger, F. G. (2019) · Human Reproduction Update · doi:10.1093/humupd/dmz027 · Cited by 657
Kalich-Philosoph, L., Roness, H., Carmely, A., Fishel-Bartal, M., Ligumsky, H., Paglin, S., Wolf, I., Kanety, H., Sredni, B., & Meirow, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005402 · Cited by 542
How do chemotherapeutic agents damage the ovary?
Morgan, S., Anderson, R. A., Gourley, C., Wallace, W. H., & Spears, N. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms022 · Cited by 409
Chemotherapy-Induced Damage to Ovary: Mechanisms and Clinical Impact
Bedoschi, G., Navarro, P. A., & Oktay, K. (2016) · Future Oncology · doi:10.2217/fon-2016-0176 · Cited by 356
Self-citation
Metadata
- Authors
- Oktem, O., & Oktay, K.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2007-10-11
- Volume
- 110
- Issue
- 10
- Pages
- 2222-2229
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1968088508
- Cited by
- 289
- References
- 17
- FWCI
- 13.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.